Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2011: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2010: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2009: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Research Abstract |
Purpose of this study was(i) establish ELISA system to detect serum anti-VEGF antibodies, and(ii) evaluate positive rate of serum anti-VEGF antibodies in patients with esophageal squamous cell carcinoma. Using a cut-off value of mean+3SD of serum anti-VEGF antibody level of healthy controls, positive rate of patients with esophageal squamous cell carcinoma was 6.6%(6/91). No clinicopathological factors were associated with presence of anti-VEGF antibodies.
|